Seroepidemiology of hepatitis E virus infection in general population in rural Durango, Mexico

Hepatitis Monthly

Volumn 14, Issue 6, 2014, Pages

  Alvarado Esquivel, Cosme ^a   Sanchez Anguiano, Luis Francisco ^a   Hernandez Tinoco, Jesus ^a  

^a UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

Author keywords

Hepatitis E virus; Mexico; Risk factors; Rural population; Seroepidemiologic studies

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E; HUMAN; MALE; MEXICO; OCCUPATION; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGY; SEROPREVALENCE; SOCIOMETRIC STATUS; TOXOPLASMA GONDII; VERY ELDERLY; WATER QUALITY;

EID: 84901944613     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.16876     Document Type: Article

References (30)

1. Aggarwal R. Hepatitis E: clinical presentation in disease-endemic areas and diagnosis. Semin Liver Dis. 2013;33(1):30-40.
2. Echevarria JM, Gonzalez JE, Lewis-Ximenez LL, Dos Santos DR, Munne MS, Pinto MA, et al. Hepatitis E virus infection in Latin America: a review. J Med Virol. 2013;85(6):1037-45.
3. Kmush B, Wierzba T, Krain L, Nelson K, Labrique AB. Epidemiology of hepatitis E in low-and middle-income countries of Asia and Africa. Semin Liver Dis. 2013;33(1):15-29.
4. Kamar N, Izopet J, Rostaing L. Hepatitis E virus infection. Curr Opin Gastroenterol. 2013;29(3):271-8.
5. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, et al. Hepatitis E. Lancet. 2012;379(9835):2477-88.
6. Sclair SN, Schiff ER. An update on the hepatitis E virus. Curr Gastroenterol Rep. 2013;15(2):304.
7. Kumar S, Subhadra S, Singh B, Panda BK. Hepatitis E virus: the current scenario. Int J Infect Dis. 2013;17(4):e228-33.
8. Dalton HR, Hunter JG, Bendall RP. Hepatitis E. Curr Opin Infect Dis. 2013;26(5):471-8.
9. Mateos-Lindemann ML, Diez-Aguilar M, Gonzalez-Galdamez A, Graus-Morales J, Moreno-Zamora A, Perez-Gracia MT. Acute, chronic and fulminant hepatitisE: seven years of experience (2004-2011). Enferm Infecc Microbiol Clin. 2013;31(9):595-8.
10. Rayis DA, Jumaa AM, Gasim GI, Karsany MS, Adam I. An outbreak of hepatitis E and high maternal mortality at Port Sudan, Eastern Sudan. Pathog Glob Health. 2013;107(2):66-8.
11. Wedemeyer H, Rybczynska J, Pischke S, Krawczynski K. Immunopathogenesis of hepatitis E virus infection. Semin Liver Dis. 2013;33(1):71-8.
12. Kamar N, Rostaing L, Izopet J. Hepatitis E virus infection in immunosuppressed patients: natural history and therapy. Semin Liver Dis. 2013;33(1):62-70.
13. Bonnet D, Kamar N, Izopet J, Alric L. Hepatitis E: an emerging disease. Rev Med Interne. 2012;33(6):328-34.
14. Alvarado-Esquivel C, Cruz-Magallanes HM, Esquivel-Cruz R, Estra-da-Martinez S, Rivas-Gonzalez M, Liesenfeld O, et al. Seroepidemiology of Toxoplasma gondii infection in human adults from three rural communities in Durango State, Mexico. J Parasitol. 2008;94(4):811-6.
15. Bronfman M, Guiscafre H, Castro V, Castro R, Gutierrez G. Strategies for improving the therapeutic patterns used in acute diarrhea in primary medical care units. II. The measurement of inequality: a methodologic strategy, analysis of the socioeconomic features of the sample. Arch Invest Med (Mex). 1988;19(4):351-60.
16. Bernal Reyes R, Licona Solis JE. Seroepidemiology of hepat tis E in the State of Hidalgo. Rev Gastroenterol Mex. 1996;61(3):233-8.
17. Alvarez-Munoz MT, Torres J, Damasio L, Gomez A, Tapia-Conyer R, Munoz O. Seroepidemiology of hepatitis E virus infection in Mexican subjects 1 to 29 years of age. Arch Med Res. 1999;30(3):251-4.
18. Dell'Amico MC, Cavallo A, Gonzales JL, Bonelli SI, Valda Y, Pieri A, et al. Hepatitis E virus genotype 3 in humans and Swine, Bolivia. Emerg Infect Dis. 2011;17(8):1488-90.
19. Bortoliero AL, Bonametti AM, Morimoto HK, Matsuo T, Reiche EM. Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Parana, Brazil. Rev Inst Med Trop Sao Paulo. 2006;48(2):87-92.
20. Trinta KS, Liberto MI, de Paula VS, Yoshida CF, Gaspar AM. Hepatitis E virus infection in selected Brazilian populations. Mem Inst Oswaldo Cruz. 2001;96(1):25-9.
21. Ibarra H, Riedemann S, Reinhardt G, Frieck P, Siegel F, Toledo C, et al. Prevalence of hepatitis E virus antibodies in blood donors and other population groups in southern Chile. Rev Med Chil. 1997;125(3):275-8.
22. Pujol FH, Favorov MO, Marcano T, Este JA, Magris M, Liprandi F, et al. Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela. J Med Virol. 1994;42(3):234-6.
23. Hannachi N, Hidar S, Harrabi I, Mhalla S, Marzouk M, Ghzel H, et al. Seroprevalence and risk factors of hepatitis E among pregnant women in central Tunisia. Pathol Biol (Paris). 2011;59(5):e115-8.
24. Alavian SM. Hepatitis E Virus Infection: A Neglected Problem in Our Region. Hepat Mon. 2007;7(3):119-21.
25. Song YJ, Park WJ, Park BJ, Lee JB, Park SY, Song CS, et al. Hepatitis E virus infections in humans and animals. Clin Exp Vaccine Res. 2014;3(1):29-36.
26. Ghorbani GA, Alavian SM, Esfahani AA, Assari S. Seroepidemiology of Hepatitis E Virus in Iranian Soldiers. Hepat Mon. 2007;7(3):123-6.
27. Taremi M, Gachkar L, MahmoudArabi S, Kheradpezhouh M, Khoshbaten M. Prevalence of antibodies to hepatitis E virus among male blood donors in Tabriz, Islamic Republic of Iran. East Mediterr Health J. 2007;13(1):98-102.
28. Colson P, Coze C, Gallian P, Henry M, De Micco P, Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis. 2007;13(4):648-9.
29. Adlhoch C, Kaiser M, Pauli G, Koch J, Meisel H. Indigenous hepatitis E virus infection of a plasma donor in Germany. Vox Sang. 2009;97(4):303-8.
30. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, et al. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med. 2006;16(2):79-83